Koss Olinger Consulting, LLC Royalty Pharma PLC Transaction History
Koss Olinger Consulting, LLC
- $1.18 Billion
- Q1 2025
A detailed history of Koss Olinger Consulting, LLC transactions in Royalty Pharma PLC stock. As of the latest transaction made, Koss Olinger Consulting, LLC holds 31,756 shares of RPRX stock, worth $1.04 Million. This represents 0.08% of its overall portfolio holdings.
Number of Shares
31,756
Previous 10,531
201.55%
Holding current value
$1.04 Million
Previous $269,000
267.29%
% of portfolio
0.08%
Previous 0.02%
Shares
2 transactions
Others Institutions Holding RPRX
# of Institutions
484Shares Held
283MCall Options Held
2.51MPut Options Held
941K-
Morgan Stanley New York, NY41MShares$1.35 Billion0.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA36.7MShares$1.21 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY23MShares$757 Million0.01% of portfolio
-
Baillie Gifford & CO13.4MShares$441 Million0.38% of portfolio
-
Swedbank Ab Stockholm, V712.2MShares$400 Million0.39% of portfolio
About Royalty Pharma plc
- Ticker RPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 437,139,008
- Market Cap $14.4B
- Description
- Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...